Vericel (VCEL) Accumulated Expenses (2011 - 2026)
Vericel (VCEL) recorded Accumulated Expenses of $17.64 million in Q2 2026, up 22.5% from $14.4 million a year earlier and up 26.3% from the prior quarter.
Powered by 
Analysis
Vericel (VCEL) Accumulated Expenses (2011 - 2026) Analysis & Trends
At the end of FY2025, Vericel reported Accumulated Expenses of $19.24 million, up 12.7% from FY2024.
- Annual Accumulated Expenses has a five-year compound annual growth rate of 11.2% (FY2020 to FY2025).
- Across earlier years, Accumulated Expenses came in at $17.07 million in FY2024 (-0.9%), $17.22 million in FY2023 (+6.3%), $16.19 million in FY2022 (+15.3%) and $14.05 million in FY2021 (+24.4%).
- Quarterly Accumulated Expenses has ranged from $10.79 million in Q1 2022 to $19.24 million in Q4 2025 over the past five years.
- On a year-over-year basis, Accumulated Expenses has increased for six consecutive quarters, with growth averaging 11.4% over the last eight quarters.
- Peak year-over-year performance for Accumulated Expenses in the last five years was growth of 27.6% in Q3 2022, against a decline of 15.9% in Q1 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $13.97 million (Q1 2026), $19.24 million (Q4 2025) and $16.29 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Vericel | 2.05 Bn | 1.47 Bn | 56.40 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17.64 Mn |
| Mar 31, 2026 | 13.97 Mn |
| Dec 31, 2025 | 19.24 Mn |
| Sep 30, 2025 | 16.29 Mn |
| Jun 30, 2025 | 14.40 Mn |
| Mar 31, 2025 | 11.42 Mn |
| Dec 31, 2024 | 17.07 Mn |
| Sep 30, 2024 | 14.34 Mn |
| Jun 30, 2024 | 12.86 Mn |
| Mar 31, 2024 | 11.03 Mn |
| Dec 31, 2023 | 17.22 Mn |
| Sep 30, 2023 | 13.63 Mn |
| Jun 30, 2023 | 13.97 Mn |
| Mar 31, 2023 | 13.11 Mn |
| Dec 31, 2022 | 16.19 Mn |
| Sep 30, 2022 | 13.95 Mn |
| Jun 30, 2022 | 12.13 Mn |
| Mar 31, 2022 | 10.79 Mn |
| Dec 31, 2021 | 14.05 Mn |
| Sep 30, 2021 | 10.93 Mn |
API Access
Vericel Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=VCEL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "VCEL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=VCEL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();